{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:29:20Z","timestamp":1787002160844,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T00:00:00Z","timestamp":1351468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1038\/aps.2012.115","type":"journal-article","created":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T09:19:09Z","timestamp":1351502349000},"page":"1518-1524","source":"Crossref","is-referenced-by-count":31,"title":["Telmisartan attenuates hepatic fibrosis in bile duct-ligated rats"],"prefix":"10.1038","volume":"33","author":[{"given":"En-tong","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-hong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,29]]},"reference":[{"key":"BFaps2012115_CR1","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jhep.2006.10.018","volume":"46","author":"RM Pereira","year":"2007","unstructured":"Pereira RM, Dos Santos RA, Teixeira MM, Leite VH, Costa LP, da Costa Dias FL, et al. The renin-angiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of angiotensin-(1\u20137). J Hepatol 2007; 46: 674\u201381.","journal-title":"J Hepatol"},{"key":"BFaps2012115_CR2","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1111\/j.1440-1746.2008.05461.x","volume":"23","author":"JS Lubel","year":"2008","unstructured":"Lubel JS, Herath CB, Burrell LM, Angus PW . Liver disease and the renin-angiotensin system: recent discoveries and clinical implications. J Gastroenterol Hepatol 2008; 23: 1327\u201338.","journal-title":"J Gastroenterol Hepatol"},{"key":"BFaps2012115_CR3","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1136\/gut.2004.062398","volume":"54","author":"G Paizis","year":"2005","unstructured":"Paizis G, Tikellis C, Cooper ME, Schembri JM, Lew RA, Smith AI, et al. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 2005; 54: 1790\u20136.","journal-title":"Gut"},{"key":"BFaps2012115_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1517\/14728221003709784","volume":"14","author":"P Castro-Chaves","year":"2010","unstructured":"Castro-Chaves P, Cerqueira R, Pintalhao M, Leite-Moreira AF . New pathways of the renin-angiotensin system: the role of ACE2 in cardiovascular pathophysiology and therapy. Expert Opin Ther Targets 2010; 14: 485\u201396.","journal-title":"Expert Opin Ther Targets"},{"key":"BFaps2012115_CR5","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1097\/HJH.0b013e32834a5a46","volume":"29","author":"T Dejima","year":"2011","unstructured":"Dejima T, Tamura K, Wakui H, Maeda A, Ohsawa M, Kanaoka T, et al. Prepubertal angiotensin blockade exerts long-term therapeutic effect through sustained ATRAP activation in salt-sensitive hypertensive rats. J Hypertens 2011; 29: 1919\u201329.","journal-title":"J Hypertens"},{"key":"BFaps2012115_CR6","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/j.1440-1681.2009.05302.x","volume":"37","author":"ML Huang","year":"2010","unstructured":"Huang ML, Li X, Meng Y, Xiao B, Ma Q, Ying SS, et al. Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors. Clin Exp Pharmacol Physiol 2010; 37: e1\u20136.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BFaps2012115_CR7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1042\/CS20080647","volume":"117","author":"JS Lubel","year":"2009","unstructured":"Lubel JS, Herath CB, Tchongue J, Grace J, Jia Z, Spencer K, et al. Angiotensin-(1\u20137), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat. Clin Sci (Lond) 2009; 117: 375\u201386.","journal-title":"Clin Sci (Lond)"},{"key":"BFaps2012115_CR8","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/hep.23421","volume":"51","author":"M Moreno","year":"2010","unstructured":"Moreno M, Gonzalo T, Kok RJ, Sancho-Bru P, van Beuge M, Swart J, et al. Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats. Hepatology 2010; 51: 942\u201352.","journal-title":"Hepatology"},{"key":"BFaps2012115_CR9","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/j.1478-3231.2009.01973.x","volume":"29","author":"KE Corey","year":"2009","unstructured":"Corey KE, Shah N, Misdraji J, Abu Dayyeh BK, Zheng H, Bhan AK, et al. The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C. Liver Int 2009; 29: 748\u201353.","journal-title":"Liver Int"},{"key":"BFaps2012115_CR10","doi-asserted-by":"publisher","first-page":"F398","DOI":"10.1152\/ajprenal.90488.2008","volume":"296","author":"MJ Soler","year":"2009","unstructured":"Soler MJ, Ye M, Wysocki J, William J, Lloveras J, Batlle D . Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan. Am J Physiol Renal Physiol 2009; 296: F398\u2013405.","journal-title":"Am J Physiol Renal Physiol"},{"key":"BFaps2012115_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jhep.2005.02.034","volume":"43","author":"L Yang","year":"2005","unstructured":"Yang L, Bataller R, Dulyx J, Coffman TM, Gines P, Rippe RA, et al. Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice. J Hepatol 2005; 43: 317\u201323.","journal-title":"J Hepatol"},{"key":"BFaps2012115_CR12","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/hep.20665","volume":"41","author":"R Bataller","year":"2005","unstructured":"Bataller R, Gabele E, Parsons CJ, Morris T, Yang L, Schoonhoven R, et al. Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats. Hepatology 2005; 41: 1046\u201355.","journal-title":"Hepatology"},{"key":"BFaps2012115_CR13","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/j.1478-3231.2010.02264.x","volume":"30","author":"D Schuppan","year":"2010","unstructured":"Schuppan D, Gorrell MD, Klein T, Mark M, Afdhal NH . The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitis. Liver Int 2010; 30: 795\u2013808.","journal-title":"Liver Int"},{"key":"BFaps2012115_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/hr.2009.74","volume":"32","author":"M Iwai","year":"2009","unstructured":"Iwai M, Horiuchi M . Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs ACE2-angiotensin-(1\u20137)-Mas receptor axis. Hypertens Res 2009; 32: 533\u20136.","journal-title":"Hypertens Res"},{"key":"BFaps2012115_CR15","doi-asserted-by":"publisher","first-page":"H1560","DOI":"10.1152\/ajpheart.00941.2004","volume":"289","author":"EA Tallant","year":"2005","unstructured":"Tallant EA, Ferrario CM, Gallagher PE . Angiotensin-(1\u20137) inhibits growth of cardiac myocytes through activation of the mas receptor. Am J Physiol Heart Circ Physiol 2005; 289: H1560\u20136.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFaps2012115_CR16","doi-asserted-by":"publisher","first-page":"F353","DOI":"10.1152\/ajprenal.00144.2004","volume":"288","author":"N Li","year":"2005","unstructured":"Li N, Zimpelmann J, Cheng K, Wilkins JA, Burns KD . The role of angiotensin converting enzyme 2 in the generation of angiotensin 1\u20137 by rat proximal tubules. Am J Physiol Renal Physiol 2005; 288: F353\u201362.","journal-title":"Am J Physiol Renal Physiol"},{"key":"BFaps2012115_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/hep.1840010511","volume":"1","author":"RG Knodell","year":"1981","unstructured":"Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431\u20135.","journal-title":"Hepatology"},{"key":"BFaps2012115_CR18","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1002\/hep.1840060619","volume":"6","author":"T Moriyama","year":"1986","unstructured":"Moriyama T, Aoyama H, Ohnishi S, Imawari M . Protective effects of fibronectin in galactosamine-induced liver failure in rats. Hepatology 1986; 6: 1334\u20139.","journal-title":"Hepatology"},{"key":"BFaps2012115_CR19","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s00535-008-2239-9","volume":"43","author":"MY Kim","year":"2008","unstructured":"Kim MY, Baik SK, Park DH, Jang YO, Suk KT, Yea CJ, et al. Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model. J Gastroenterol 2008; 43: 889\u201396.","journal-title":"J Gastroenterol"},{"key":"BFaps2012115_CR20","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.biopha.2007.10.020","volume":"62","author":"G Karimian","year":"2008","unstructured":"Karimian G, Mohammadi-Karakani A, Sotoudeh M, Ghazi-Khansari M, Ghobadi G, Shakiba B . Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats. Biomed Pharmacother 2008; 62: 312\u20136.","journal-title":"Biomed Pharmacother"},{"key":"BFaps2012115_CR21","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.bbrc.2007.10.083","volume":"364","author":"H Jin","year":"2007","unstructured":"Jin H, Yamamoto N, Uchida K, Terai S, Sakaida I . Telmisartan prevents hepatic fibrosis and enzyme-altered lesions in liver cirrhosis rat induced by a choline-deficient L-amino acid-defined diet. Biochem Biophys Res Commun 2007; 364: 801\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFaps2012115_CR22","doi-asserted-by":"publisher","first-page":"G1094","DOI":"10.1152\/ajpgi.00365.2010","volume":"300","author":"K Kaji","year":"2011","unstructured":"Kaji K, Yoshiji H, Kitade M, Ikenaka Y, Noguchi R, Shirai Y, et al. Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats. Am J Physiol Gastrointest Liver Physiol 2011; 300: G1094\u2013104.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFaps2012115_CR23","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.7150\/ijbs.7.1077","volume":"7","author":"V Sukumaran","year":"2011","unstructured":"Sukumaran V, Veeraveedu PT, Gurusamy N, Yamaguchi K, Lakshmanan AP, Ma M, et al. Cardioprotective effects of telmisartan against heart failure in rats induced by experimental autoimmune myocarditis through the modulation of angiotensin-converting enzyme-2\/angiotensin 1\u20137\/mas receptor axis. Int J Biol Sci 2011; 7: 1077\u201392.","journal-title":"Int J Biol Sci"},{"key":"BFaps2012115_CR24","doi-asserted-by":"publisher","first-page":"F1523","DOI":"10.1152\/ajprenal.00426.2009","volume":"298","author":"M Dilauro","year":"2010","unstructured":"Dilauro M, Zimpelmann J, Robertson SJ, Genest D, Burns KD . Effect of ACE2 and angiotensin-(1\u20137) in a mouse model of early chronic kidney disease. Am J Physiol Renal Physiol 2010; 298: F1523\u201332.","journal-title":"Am J Physiol Renal Physiol"},{"key":"BFaps2012115_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1667\/RR2560.1","volume":"176","author":"KR Conner","year":"2011","unstructured":"Conner KR, Forbes ME, Lee WH, Lee YW, Riddle DR . AT1 receptor antagonism does not influence early radiation-induced changes in microglial activation or neurogenesis in the normal rat brain. Radiat Res 2011; 176: 71\u201383.","journal-title":"Radiat Res"},{"key":"BFaps2012115_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jhep.2007.03.008","volume":"47","author":"CB Herath","year":"2007","unstructured":"Herath CB, Warner FJ, Lubel JS, Dean RG, Jia Z, Lew RA, et al. Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1\u20137) levels in experimental biliary fibrosis. J Hepatol 2007; 47: 387\u201395.","journal-title":"J Hepatol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps2012115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2012115","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2012115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:27:02Z","timestamp":1684398422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps2012115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,29]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["BFaps2012115"],"URL":"https:\/\/doi.org\/10.1038\/aps.2012.115","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,29]]}}}